1. Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors.
    Stanislav Kalinin et al, 2021, Int J Mol Sci CrossRef
  2. Anti-miR-135/SPOCK1 axis antagonizes the influence of metabolism on drug response in intestinal/colon tumour organoids
    Roya Babaei-Jadidi et al, 2022, Oncogenesis CrossRef
  3. The expression and survival significance of sodium glucose transporters in pancreatic cancer
    Jiali Du et al, 2022, BMC Cancer CrossRef
  4. Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components
    Entaz Bahar et al, 2022, Cancers CrossRef
  5. Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma
    Guihong Lu et al, 2022, Nat Commun CrossRef
  6. Role of AMPK in Regulation of Oxaliplatin-Resistant Human Colorectal Cancer
    Sun Young Park et al, 2022, Biomedicines CrossRef
  7. On the Feasibility of Using an Ultra-Fast DirectMS1 Method of Proteome-Wide Analysis for Searching Drug Targets in Chemical Proteomics
    Elizaveta M. Solovyeva et al, 2022, Biochemistry Moscow CrossRef
  8. null
    Cláudia Silva et al, 2022 CrossRef
  9. Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction
    Chien-Liang Lin et al, 2023, Phytomedicine CrossRef
  10. The role of metabolic reprogramming in pancreatic cancer chemoresistance
    Chang Liu et al, 2023, Front. Pharmacol. CrossRef
  11. Modulating Glycolysis to Improve Cancer Therapy
    Chaithanya Chelakkot et al, 2023, IJMS CrossRef
  12. Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells – a potential contribution to the predictive, preventive, and personalized medicine
    Alena Mazurakova et al, 2023, Journal of Advanced Research CrossRef
  13. Epigenetic–Metabolic Interplay in the DNA Damage Response and Therapeutic Resistance of Breast Cancer
    Chandrima Das et al, 2023 CrossRef
  14. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
    Xue Hu et al, 2023 CrossRef
  15. Orchestral role of lipid metabolic reprogramming in T-cell malignancy
    Arundhati Mehta et al, 2023, Front. Oncol. CrossRef
  16. Nanobiotechnology-based treatment strategies for malignant relapsed glioma
    Qiujun Qiu et al, 2023, Journal of Controlled Release CrossRef
  17. Sensitivity of Lewis lung carcinoma cells to glycolysis and glutaminolysis inhibition
    Denis Kolesnik et al, 2023, InterConf+ CrossRef
  18. β-HB treatment reverses sorafenib resistance by shifting glycolysis–lactate metabolism in HCC
    Fat-Moon Suk et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  19. Adaptive responses of neuronal cells to chronic endoplasmic reticulum (ER) stress
    Thu Nguyen Minh Pham et al, 2023, Redox Biology CrossRef
  20. Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma
    Kai-Fang Hu et al, 2023, Cancer Cell Int CrossRef
  21. Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway
    Sichen Di et al, 2023, Cancer Cell Int CrossRef
  22. Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis
    Yan Zhou et al, 2023, Phytotherapy Research CrossRef
  23. Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells
    Yuchuan Yang et al, 2023, International Journal of Hyperthermia CrossRef
  24. Chemotactic nanomotor for multimodal combined therapy of glioblastoma
    Ting Li et al, 2024, Sci. China Chem. CrossRef
  25. Diapause-like Drug-Tolerant Persister State: The Key to Nirvana Rebirth
    Han-Lin Chen et al, 2024, Medicina CrossRef
  26. STK32C modulates doxorubicin resistance in triple-negative breast cancer cells via glycolysis regulation
    Huawei Xiao et al, 2024, Mol Cell Biochem CrossRef